Hartford Investment Management Co (HIMCO)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$231K Buy
13,796
+3,257
+31% +$54.6K 0.01% 496
2025
Q1
$162K Sell
10,539
-49
-0.5% -$753 0.01% 495
2024
Q4
$233K Buy
10,588
+26
+0.2% +$573 0.01% 495
2024
Q3
$190K Buy
10,562
+51
+0.5% +$919 0.01% 493
2024
Q2
$171K Buy
10,511
+180
+2% +$2.93K 0.01% 497
2024
Q1
$146K Buy
10,331
+10
+0.1% +$141 0.01% 497
2023
Q4
$108K Hold
10,321
﹤0.01% 497
2023
Q3
$105K Buy
10,321
+204
+2% +$2.08K ﹤0.01% 510
2023
Q2
$76.2K Buy
+10,117
New +$76.2K ﹤0.01% 511
2022
Q3
Sell
-13,006
Closed -$98K 549
2022
Q2
$98K Sell
13,006
-21
-0.2% -$158 ﹤0.01% 540
2022
Q1
$122K Sell
13,027
-7,084
-35% -$66.3K ﹤0.01% 538
2021
Q4
$161K Sell
20,111
-169
-0.8% -$1.35K ﹤0.01% 541
2021
Q3
$198K Sell
20,280
-3,045
-13% -$29.7K 0.01% 542
2021
Q2
$231K Sell
23,325
-433
-2% -$4.29K 0.01% 536
2021
Q1
$274K Sell
23,758
-2,481
-9% -$28.6K 0.01% 534
2020
Q4
$253K Sell
26,239
-9
-0% -$87 0.01% 526
2020
Q3
$236K Sell
26,248
-699
-3% -$6.29K 0.01% 517
2020
Q2
$332K Buy
26,947
+229
+0.9% +$2.82K 0.01% 505
2020
Q1
$240K Buy
26,718
+417
+2% +$3.75K 0.01% 529
2019
Q4
$258K Sell
26,301
-1,538
-6% -$15.1K 0.01% 541
2019
Q3
$192K Sell
27,839
-485
-2% -$3.35K 0.01% 546
2019
Q2
$261K Buy
28,324
+1,748
+7% +$16.1K 0.01% 523
2019
Q1
$417K Sell
26,576
-3,005
-10% -$47.2K 0.01% 512
2018
Q4
$456K Buy
29,581
+902
+3% +$13.9K 0.01% 526
2018
Q3
$618K Sell
28,679
-1,150
-4% -$24.8K 0.02% 524
2018
Q2
$725K Buy
29,829
+1,757
+6% +$42.7K 0.02% 506
2018
Q1
$480K Sell
28,072
-2,982
-10% -$51K 0.01% 552
2017
Q4
$588K Sell
31,054
-102
-0.3% -$1.93K 0.01% 550
2017
Q3
$548K Sell
31,156
-519
-2% -$9.13K 0.01% 552
2017
Q2
$1.05M Sell
31,675
-2,950
-9% -$98K 0.02% 534
2017
Q1
$1.11M Sell
34,625
-12,357
-26% -$396K 0.02% 530
2016
Q4
$1.7M Buy
+46,982
New +$1.7M 0.03% 491